7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Arthropathy, Neurogenic D001177 1 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Hemarthrosis D006395 1 associated lipids
Cherubism D002636 1 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Mandibular Injuries D008338 1 associated lipids
Diabetic Foot D017719 1 associated lipids
Emphysema D004646 1 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Spondylarthropathies D025242 1 associated lipids
Ankylosis D000844 1 associated lipids
Jaw, Edentulous D007575 1 associated lipids
Chondrocalcinosis D002805 1 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Carcinoid Heart Disease D002275 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Prosthesis Failure D011475 1 associated lipids
Spondylarthritis D025241 1 associated lipids
Foot Injuries D018409 1 associated lipids
Synovitis, Pigmented Villonodular D013586 1 associated lipids
Periostitis D010522 1 associated lipids
Jaw, Edentulous, Partially D007576 1 associated lipids
Bone Diseases, Endocrine D001849 1 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Osteopetrosis D010022 1 associated lipids
Histiocytosis, Langerhans-Cell D006646 1 associated lipids
Tooth Resorption D014091 1 associated lipids
Vascular Calcification D061205 1 associated lipids
Angioid Streaks D000793 1 associated lipids
Atrial Remodeling D064752 1 associated lipids
Chondroblastoma D002804 1 associated lipids
Hyperostosis D015576 1 associated lipids
Hip Dislocation D006617 1 associated lipids
Rupture, Spontaneous D012422 1 associated lipids
Malocclusion, Angle Class I D008311 1 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Peri-Implantitis D057873 1 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
Hashimoto Disease D050031 1 associated lipids
Legg-Calve-Perthes Disease D007873 1 associated lipids
Fluorosis, Dental D009050 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
POEMS Syndrome D016878 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Osteolysis, Essential D010015 1 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Kwon A et al. Serum Osteoprotegerin Is Associated With Calcified Carotid Plaque: A Strobe-Compliant Observational Study. 2016 Medicine (Baltimore) pmid:27082605
Hsu BG et al. Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study. 2016 Medicine (Baltimore) pmid:27082570
Zhang L et al. Effects of IL-10 and glucose on expression of OPG and RANKL in human periodontal ligament fibroblasts. 2016 Braz. J. Med. Biol. Res. pmid:27074164
Song DH et al. Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis. 2016 Med. Sci. Monit. pmid:27068490
Stuss M et al. Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. 2016 Endokrynol Pol pmid:26884284
Gluba-Brzózka A et al. Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study. 2016 Lipids Health Dis pmid:26843213
Gautam J et al. An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. 2016 J. Pharm. Pharmacol. pmid:27265669
Bumdelger B et al. Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms. 2016 PLoS ONE pmid:26783750
Owen S et al. Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. 2016 Int. J. Oncol. pmid:26781475
Maser RE et al. Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. 2016 J. Diabetes Complicat. pmid:26775555
Gottesman GS et al. Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. 2016 Am. J. Med. Genet. A pmid:26762549
Totoson P et al. Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation. 2016 PLoS ONE pmid:26761790
Kuroda Y et al. Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion. 2016 PLoS ONE pmid:26751951
Bougioukli S et al. Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect. 2016 Bone pmid:26723577
Kobayashi Y et al. Regulation of bone metabolism by Wnt signals. 2016 J. Biochem. pmid:26711238
Chen Z et al. Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway. 2016 Int. J. Mol. Med. pmid:26677102
Melchiorre D et al. Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A. 2016 Haematologica pmid:26494839
Wang HL et al. Protein biomarkers and microbial profiles in peri-implantitis. 2016 Clin Oral Implants Res pmid:26424287
Iezaki T et al. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption. 2016 J. Bone Miner. Res. pmid:26391411
Meijome TE et al. C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis. 2016 J. Cell. Biochem. pmid:26375403
Pietschmann P et al. Immunology of Osteoporosis: A Mini-Review. 2016 Gerontology pmid:26088283
Kainuma S et al. Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts. 2016 Mol Med Rep pmid:26935864
Shimazaki E et al. TGF-β and Physiological Root Resorption of Deciduous Teeth. 2016 Int J Mol Sci pmid:28035998
Bolamperti S et al. Evidence for Altered Canonical Wnt Signaling in the Trabecular Bone of Elderly Postmenopausal Women with Fragility Femoral Fracture. 2016 Biomed Res Int pmid:27999816
Li Y et al. Osteoprotegerin polymorphisms are associated with alcohol-induced osteonecrosis of femoral head in Chinese Han population from Henan province. 2016 J. Genet. pmid:27994198
Gómez-Vaquero C et al. Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis. 2016 PLoS ONE pmid:27911913
Zhang L et al. Role of Osteoprotegerin (OPG) in Bone Marrow Adipogenesis. 2016 Cell. Physiol. Biochem. pmid:27898403
Biscetti F et al. RANK/RANKL/OPG pathway: genetic association with history of ischemic stroke in Italian population. 2016 Eur Rev Med Pharmacol Sci pmid:27874938
Liu FQ et al. Effects of Salt Loading on Plasma Osteoprotegerin Levels and Protective Role of Potassium Supplement in Normotensive Subjects. 2016 Circ. J. pmid:27867157
Kim CS et al. Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. 2016 PLoS ONE pmid:27855207
Li XJ et al. Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice. 2016 Int. J. Mol. Med. pmid:27840967
Zhou J and Zhao Y Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-implantitis Susceptibility in a Chinese Han Population. 2016 Med. Sci. Monit. pmid:27828936
Ostrowska Z et al. TGF-β1, bone metabolism, osteoprotegerin, and soluble receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. 2016 Endokrynol Pol pmid:27828689
Kan C et al. Cancer Cell Colonisation in the Bone Microenvironment. 2016 Int J Mol Sci pmid:27782035
Huang HM et al. Effects of Roughly Focused Extracorporeal Shock Waves Therapy on the Expressions of Bone Morphogenetic Protein-2 and Osteoprotegerin in Osteoporotic Fracture in Rats. 2016 Chin. Med. J. pmid:27779163
Kamata R et al. EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4. 2016 PLoS ONE pmid:27764222
Liu HJ et al. Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System. 2016 PLoS ONE pmid:27764190
Songia P et al. Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. 2016 J. Mol. Cell. Cardiol. pmid:27338002
Li Y et al. OPG and RANKL polymorphisms are associated with alcohol-induced osteonecrosis of the femoral head in the north area of China population in men. 2016 Medicine (Baltimore) pmid:27336899
Dolan EB et al. Thermally induced osteocyte damage initiates pro-osteoclastogenic gene expression in vivo. 2016 J R Soc Interface pmid:27335224
Kassem A et al. Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL. 2016 PLoS ONE pmid:27311019
Wang JH et al. Dickkopf-1 negatively regulates the expression of osteoprotegerin, a key osteoclastogenesis inhibitor, by sequestering Lrp6 in primary and metastatic lytic bone lesions. 2016 Medicine (Baltimore) pmid:27310953
Yamada C et al. TGF-β in jaw tumor fluids induces RANKL expression in stromal fibroblasts. 2016 Int. J. Oncol. pmid:27279422
He M et al. Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis. 2016 Mol Med Rep pmid:27277157
Ye C et al. [Effect of MT01/PEN complexes on the expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in human osteoblast-like cell line MG63]. 2016 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:27266195
Bernardi S et al. Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. 2016 Biomed Res Int pmid:27200369
Wei CC et al. Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis. 2016 Mediators Inflamm. pmid:27199510
Usategui-Martín R et al. VAV3 Gene Polymorphism Is Associated with Paget's Disease of Bone. 2016 Genet Test Mol Biomarkers pmid:27172236
Sun J et al. Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. 2016 Int. Immunopharmacol. pmid:27576059
Li B et al. Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity. 2016 Int J Mol Sci pmid:27110777

Table of Content